Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Location: Irvine CA, Orange CA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06654037
Phase1, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Irvine CA, Orange CA, Salt Lake City UT, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Location: Irvine CA, Orange CA, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687123
Phase1, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Irvine CA, Orange CA, Duarte CA, Goodyear AZ, Tucson AZ,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase3, Recruiting
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Irvine CA, Orange CA, Los Angeles CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT04633239
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: Irvine CA, Orange CA, Oklahoma City OK, Fairway KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase1, Recruiting
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
for
Advanced Malignant Solid Neoplasm,
Location: Irvine CA, Orange CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05691491
Phase1, Phase2, Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for
Carcinoma, Non-Small-Cell Lung,
Location: Irvine CA, Orange CA, Sacramento CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05208762
Phase1, Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
for
Metastatic Castration-resistant Prostate Cancer
Location: Irvine CA, Duarte CA, Stanford CA, Cleveland OH,
Sponsor: Full-Life Technologies GmbH
Sex: Male
Age: 18+
Code: NCT06492122
Phase1, Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Irvine CA, Orange CA, Los Angeles CA, Bakersfield CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: Irvine CA, Orange CA, Riverside CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05256225
Phase3, Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for
Metastatic Malignant Solid Neoplasm,
Location: Irvine CA, Orange CA, Upland CA, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05372614
Phase1, Recruiting
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
for
Recurrent Plasmablastic Lymphoma,
Location: Irvine CA, Orange CA, Duarte CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07332507
Phase1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Irvine CA, Orange CA, Duarte CA, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase1, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Irvine CA, Orange CA, Duarte CA, Bakersfield CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase3, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Irvine CA, Orange CA, Los Angeles CA, Bakersfield CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase3, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Irvine CA, Orange CA, Beverly Hills CA, Los Angeles CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Irvine CA, Orange CA, Yorba Linda CA, Beverly Hills CA,